Cargando…
A novel phosphorylation site involved in dissociating RAF kinase from the scaffolding protein 14-3-3 and disrupting RAF dimerization
Rapidly accelerated fibrosarcoma (ARAF, BRAF, CRAF) kinase is central to the MAPK pathway (RAS–RAF–MEK–ERK). Inactive RAF kinase is believed to be monomeric, autoinhibited, and cytosolic, while activated RAF is recruited to the membrane via RAS-GTP, leading to the relief of autoinhibition, phosphory...
Autores principales: | Yu, Alison, Nguyen, Duc Huy, Nguyen, Thomas Joseph, Wang, Zhihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520314/ https://www.ncbi.nlm.nih.gov/pubmed/37625591 http://dx.doi.org/10.1016/j.jbc.2023.105188 |
Ejemplares similares
-
Phosphorylation of RAF Kinase Dimers Drives Conformational Changes that Facilitate Transactivation
por: Jambrina, Pablo G., et al.
Publicado: (2015) -
Targeting the Raf kinases in human cancer: the Raf dimer dilemma
por: Durrant, David E, et al.
Publicado: (2018) -
RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
por: Jin, Ting, et al.
Publicado: (2017) -
Interactome dynamics of RAF1-BRAF kinase monomers and dimers
por: Iglesias-Martinez, Luis F., et al.
Publicado: (2023) -
The mechanism of Raf activation through dimerization
por: Zhang, Mingzhen, et al.
Publicado: (2021)